The findings suggest the evaluation of molecular biomarkers for Alzheimer’s disease should be adjusted for race, as African American patients were found to have lower levels of tau—a key biomarker used to identify the disease, according to research published online Jan. 7 in JAMA Neurology.

An AI-driven approach for detecting an early sign of diabetic retinopathy achieved an accuracy rate of more than 98 percent, according to a study published in Computers in Biology and Medicine. The results could mean a quicker and cheaper solution for diagnosing the disease earlier and possibly prevent loss of eyesight.

A team of Dutch researchers has developed a real-time hybrid fluoroscopic and nuclear imaging detector that may aid interventional radiology (IR) procedures such as radioembolization, according to authors of a Jan. 8 study published in Radiology.

Healthcare providers should consider treating men and women with glioblastoma (GBM) in different ways, according to a study published in Science Translational Medicine.

Researchers at the University of Cincinnati (UC) have received a $3.2 million grant from the National Institute of Neurological Diseases (NINDS) to study the use of neuroimaging to pinpoint the risk factors of stroke recurrence.

Radiotherapy combined with chemotherapy resulted in better five-year survival in patients with early-stage pediatric Hodgkin lymphoma (HL) than chemotherapy alone, reported authors of a Jan. 3 study published in JAMA Oncology.

Researchers have enrolled the first patient for the Stereotactic MRI-guided On-table Adaptive Radiation Therapy (SMART) Trial, a multi-center clinical trial that will investigate the benefits of MRI-guided, high-dose radiation therapy on patients with inoperable pancreatic cancer.

New research suggests the percentage of women who undergo cervical cancer screenings is much lower than national data has reported, according to a Mayo Clinic study published in the Journal of Women’s Health.